Komodo Health built what it calls the Healthcare Map — a massive dataset that links de-identified patient records across claims, prescriptions, lab results, and clinical encounters to create a near-complete picture of patient journeys throughout the U.S. healthcare system. Founded in 2014, the company processes data covering over 330 million patients, giving pharma companies, life sciences firms, payers, and providers unprecedented visibility into how diseases progress and treatments perform in the real world.
The platform powers several products. Aperture is the analytics suite that lets users explore patient pathways, identify treatment patterns, and benchmark provider performance. Sentinel tracks real-time disease surveillance and outbreak monitoring. Prism supports clinical trial recruitment by finding eligible patients based on real-world diagnostic and treatment history. These tools help pharmaceutical companies understand where their drugs fit in treatment sequences and identify underserved patient populations.
Komodo raised over $600 million in venture funding, with a valuation exceeding $3.5 billion at its last round. The company works with most of the top 20 pharmaceutical companies and several major health systems. Its team of roughly 600 employees includes a large contingent of data scientists and health economists. What separates Komodo from competitors is the breadth and depth of its linked dataset — combining open and closed claims with clinical data gives a much richer view than any single data source alone.
